← Leaderboards
Paul Northcott
St. Jude Children'S Research Hospital
$7,792,208
Attributed
$7,792,208
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,792,208 · 6
By mechanism
R01$5,210,961 · 3
P01$2,124,742 · 2
R21$456,505 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- John D Schuetz$14,518,241
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectTumorMolecularPathogenesisPre-Clinical ModelExhibitsGenesEffective TherapySubgroupGenomicsMedulloblastomaSeriesGeneticShh GeneMutationTumorigenesisLinkChildImproved OutcomeDiagnosisChildhood Malignant Brain TumorMalignant NeoplasmsChildhood Brain NeoplasmInsight
Grant awards (17)
Mapping the Cerebellar Origins of Medulloblastoma Subgroups$688,762
R01 · FY2025 · CA · contact PI
Deconstructing pineoblastoma origins to advance disease biology, modeling, and therapy$578,059
R01 · FY2025 · CA · contact PI
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene$450,558
P01 · FY2025 · CA · contact PI
Mapping the Cerebellar Origins of Medulloblastoma Subgroups$656,856
R01 · FY2024 · CA · contact PI
Deconstructing pineoblastoma origins to advance disease biology, modeling, and therapy$598,608
R01 · FY2024 · CA · contact PI
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene$428,031
P01 · FY2024 · CA · contact PI
Mapping the Cerebellar Origins of Medulloblastoma Subgroups$754,116
R01 · FY2023 · CA · contact PI
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene$446,877
P01 · FY2023 · CA · contact PI
Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma$410,606
R01 · FY2022 · CA · contact PI
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene$348,718
P01 · FY2022 · CA · contact PI
Cerebrospinal fluid derived circulating tumor DNA as a clinically relevant biomarker in medulloblastoma$246,714
R21 · FY2022 · CA · contact PI
Characterization of ELP1 as a novel SHH medulloblastoma predisposition gene$450,558
P01 · FY2021 · CA · contact PI
Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma$410,606
R01 · FY2021 · CA · contact PI
Cerebrospinal fluid derived circulating tumor DNA as a clinically relevant biomarker in medulloblastoma$209,791
R21 · FY2021 · CA · contact PI
Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma$368,742
R01 · FY2020 · CA · contact PI
Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma$357,678
R01 · FY2019 · CA · contact PI
Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma$386,928
R01 · FY2018 · CA · contact PI